Currently, there are 133.27M common shares owned by the public and among those 121.37M shares have been available to trade.
The company’s stock has a 5-day price change of 33.11% and -0.59% over the past three months. CVNA shares are trading 9.00% year to date (YTD), with the 12-month market performance up to 152.72% higher. It has a 12-month low price of $67.61 and touched a high of $292.84 over the same period. CVNA has an average intraday trading volume of 4.40 million shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by 12.91%, -1.91%, and 17.15% respectively.
Institutional ownership of Carvana Co (NYSE: CVNA) shares accounts for 87.10% of the company’s 133.27M shares outstanding.
It has a market capitalization of $47.26B and a beta (3y monthly) value of 3.66. The stock’s trailing 12-month PE ratio is 140.98, while the earnings-per-share (ttm) stands at $1.57. The company has a PEG of 2.88 and a Quick Ratio of 2.44 with the debt-to-equity ratio at 4.88. Price movements for the stock have been influenced by the stock’s volatility, which stands at 9.06% over the week and 8.60% over the month.
Analysts forecast that Carvana Co (CVNA) will achieve an EPS of 0.7 for the current quarter, 0.88 for the next quarter and 4.87 for current fiscal year. The lowest estimate earnings-per-share for the quarter is 0.51 while analysts give the company a high EPS estimate of 0.51. Comparatively, EPS for the current quarter was 0.23 a year ago. Earnings per share for the fiscal year are expected to increase by 76.13%, and 45.45% over the next financial year.
Looking at the support for the CVNA, a number of firms have released research notes about the stock. Morgan Stanley stated their Overweight rating for the stock in a research note on March 25, 2025, with the firm’s price target at $260-$280. Piper Sandler coverage for the Carvana Co (CVNA) stock in a research note released on March 20, 2025 offered a Overweight rating with a price target of $225. Citigroup was of a view on January 08, 2025 that the stock is Buy, while RBC Capital Mkts gave the stock Outperform rating on January 07, 2025, issuing a price target of $270- $280. Morgan Stanley on their part issued Equal-Weight rating on November 05, 2024.
